This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Interactions

Authoring team

  • patients with seafood allergies should avoid taking glucosamine (1) *
    • this is because glucosamine is manufactured by processing the crushed shells of crustaceans and therefore may lead to an allergic reaction in individuals who are allergic to seafood
  • there have been reports suggesting an interaction between warfarin and glucosamine (an increase in INR has been noted in patients taking glucosamine supplements)
    • mechanism of any interaction is unclear however, patients on warfarin are recommended not to take glucosamine (1)

* there are differing statements regarding the use of glucosamine products and in patients with a history of shell fish allergy:

  • The Anaphylaxis Campaign advises people with a history of shellfish allergy who wish to take glucosamine to be cautious, and ask for shellfish-free preparations (2); similarly, the Summary of Product Characteristics (SPC) for the licensed brands of glucosamine (Alateris, Dolenio, Glusartel and YOINTY) all contraindicate use of glucosamine in patients allergic to shellfish (3,4,5,6)
  • an NHS review stated (7):
    • "..Glucosamine supplements are either produced synthetically or derived from the shells of shellfish, and should not precipitate allergic reactions in patients sensitive to shellfish. However, some sources contraindicate or recommend cautious use of these products in patients allergic to shellfish...."

Reference:

  1. Current Problems in Pharmacovigilance 2006;31:1-12.
  2. Anaphylaxis Campaign. Shellfish Allergy: The Facts [Internet]. Last updated September 2019 [cited 10/2/20]. Available at www.anaphylaxis.org.uk/wp-content/uploads/2019/09/Shellfish-Sep-2019.pdf.
  3. Laboratoires Expanscience. Ltd. Summary of Product Characteristics. Alateris 625mg tablets. Date of revision of text 1/11/17 [cited 4/2/20]. Available at www.mhra.gov.uk/spc-pil/.
  4. Mylan Products Ltd. Summary of Product Characteristics. Glusartel 1500mg powder for oral solution. Date of revision of text 5/2/19 [cited 4/2/20]. Available at www.mhra.gov.uk/spc-pil/.
  5. Blue Bio Pharmaceuticals Ltd. Summary of Product Characteristics. Dolenio 1500mg film coated tablets. Date of revision of text 13/08/15 [cited 4/2/20]. Available at www.mhra.gov.uk/spc-pil/.
  6. Reig Jofre UK Ltd. Summary of Product Characteristics. YOINTY 625mg hard capsules. Date of revision of text 10/12/19 [cited 4/2/20]. Available at www.mhra.gov.uk/spc-pil/.
  7. NHS Specialist Pharmacy Service (February 2020). Glucosamine – what are the adverse effects?

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.